The European Medicines Agency (EMA) has released a new guideline on clinical trials conducted to assess chronic obstructive pulmonary disease (COPD) products, updating an existing guideline regulators ...

Please provide your email address to receive an email when new articles are posted on . Among both women and men with COPD, less than 50% received maintenance inhaler therapy. Less than 70% received ...

The UK's coastal ambient air quality, often perceived as inherently healthpromoting, contrasts with the poor health outcomes ...

The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk, and pulmonary hypertension. Claus F. Vogelmeier, MD, chair of the GOLD ...

Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...

These findings follow previously announced positive top-line results from two other global Phase 3 clinical studies, OBERON (NCT05166889) and TITANIA (NCT05158387), showing that tozorakimab at a ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz ...